1217820-69-3
Chemical Structure
Emtricitabine-13C,15N2
Synonym(s): BW1592-13C,15N2
- CAS No.: 1217820-69-3
- Formula:C713CH10FN15N2O3S
- Molecular Weight:250.23
IUPAC Name: 4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one-2-13C-1,3-15N2
InChIKey: XQSPYNMVSIKCOC-SJLFXUEQSA-N
SMILES: O=[13C]1[15N](C=C(C(N)=[15N]1)F)[C@H]2O[C@H](SC2)CO
Biological Activity: Emtricitabine-13C,15N2 (BW1592-13C,15N2) is a 13C- and 15N-labeled Emtricitabine (HY-17427). Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Emtricitabine-13C,15N2 | Emtricitabine-13C,15N2 (BW1592-13C,15N2) is a 13C- and 15N-labeled Emtricitabine (HY-17427). Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine (Standard) | 99.98% | Emtricitabine (Standard) is the analytical standard of Emtricitabine. This product is intended for research and analytical applications. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-15N,d2 | 97.64% | Emtricitabine-15N,d2 is a 15N-labeled and deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine-d2 | Emtricitabine-d2 (BW1592-d2) is deuterium labeled Emtricitabine. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Emtricitabine | 99.97% | Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral agent for the treatment of HIV infection. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||